Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
March 26, 2024
When we launched Pandemic Proof, many countries were still in the throes of the health and economic shocks of COVID-19. Lessons learned from the pandemic were still fresh. And the visibility and urgency of the pandemic catalyzed some important policy action, including the establishment of innovative...
Blog Post
March 20, 2024
In global development and global health circles, the euphemism “graduation” refers to the “transition” to “sustainability,” another euphemism for the reduction in, and ultimately ending of, support from a donor to a recipient country. But what happens to countries after they graduate? In this piece ...
Blog Post
March 18, 2024
Today, Dr. Sania Nishtar assumes her role as Gavi's new CEO. A lot has changed—both within Gavi and in the external environment—since the process began to replace Dr. Seth Berkley, who stepped down last year. Dr. Nishtar’s appointment comes at a critical time for Gavi. As CEO, Dr. Nishtar will play ...
Blog Post
March 12, 2024
There is no way that poverty can be fully tackled without policies designed to address the multiple disadvantages faced by people due to the combination of ascribed attributes including gender, age, race, ethnicity, disability, migration status, and sexual orientation and gender identity (SOGI). And...
Blog Post
March 08, 2024
For nearly 25 years, innovation has been core to Gavi’s success in accelerating vaccine introductions in lower-income countries. Building on this track record, Gavi has a high-impact opportunity to sharpen its focus on scaling innovations for systems improvement in its next five-year strategic perio...
Blog Post
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...
POLICY PAPERS
January 30, 2024
For nearly 25 years, Gavi has delivered impact and value for money and remained one of the most successful global health initiatives. Gavi’s success has been driven by its use of three primary levers: (1) accelerating new vaccine introductions, (2) increasing equitable immunization coverage, and (3)...
Blog Post
January 09, 2024
Child vaccination is one of the most powerful and cost-effective tools to save lives. But just how good is the data that we’re using to track progress on this life-saving intervention? In this piece, we examine trends in the quality of government-produced vaccination data. Our main message is that r...